BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3502154)

  • 21. [Immunologic reactivity of the body in sarcoidosis patients].
    Chernushenko EF; Goncharova SI; Kogosova LS
    Klin Med (Mosk); 1983 Dec; 61(12):44-9. PubMed ID: 6608033
    [No Abstract]   [Full Text] [Related]  

  • 22. [In vitro models for the analysis of inflammatory processes in sarcoidosis].
    Strausz J; Müller-Quernheim J
    Pneumologie; 1990 Mar; 44(3):694-8. PubMed ID: 2158089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of serum on lymphocyte transformation by phytohemagglutinin in patients with intrathoracic sarcoidosis.
    Terasawa M
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):69-85. PubMed ID: 6205448
    [No Abstract]   [Full Text] [Related]  

  • 24. Type 1-like helper T cell lines responsive to autologous peripheral blood monocytes established from two patients with sarcoidosis.
    Kawakami K; Owan I; Kaneshima H; Saito A
    Sarcoidosis; 1995 Sep; 12(2):111-7. PubMed ID: 8532957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the serum of patients with an active form of pulmonary sarcoidosis on the biological activity of lymphocytes and leukocytes of healthy persons].
    Wolska-Goszka L
    Pol Tyg Lek; 1984 Feb; 39(7):209-13. PubMed ID: 6379620
    [No Abstract]   [Full Text] [Related]  

  • 26. [T-lymphocyte subpopulations in bronchoalveolar lavage in pulmonary sarcoidosis and other interstitial pulmonary diseases].
    Petrek M; Kolek V
    Cas Lek Cesk; 1993 Jun; 132(12):365-8. PubMed ID: 8343944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
    Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interleukin 2 production in patients with thyroid diseases].
    Malaĭtsev VV; Bogdanova IM; Shatsova EN
    Biull Eksp Biol Med; 1986 May; 101(5):594-6. PubMed ID: 3486682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [IL-1, TNF and IL-6 production by alveolar mononuclear cells in patients with sarcoidosis].
    Pejnović N; Tomić O; Vojvodić D; Djordjević N; Jovicić Z; Kukić Z; Dangubić V; Colić M; Dujić A
    Srp Arh Celok Lek; 1994; 122 Suppl 1():96-7. PubMed ID: 18173203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.
    Yoshioka K; Kakumu S; Murakami H; Fukui K
    Clin Exp Immunol; 1984 Jun; 56(3):669-76. PubMed ID: 6235072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis.
    Hunninghake GW; Bedell GN; Zavala DC; Monick M; Brady M
    Am Rev Respir Dis; 1983 Oct; 128(4):634-8. PubMed ID: 6226225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible afferent limb immune defect in sarcoid lymphocytes.
    Ogunye O; Young R
    East Afr Med J; 1982 Mar; 59(3):199-205. PubMed ID: 6982809
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological aspects of pulmonary granulomatosis with special reference to sarcoidosis].
    Girard JP; Cuevas M; Fernandes B
    Schweiz Med Wochenschr; 1977 Feb; 107(6):175-8. PubMed ID: 299956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bronchoalveolar lavage: an approach to the immunopathogenesis of interstitial lung diseases of unknown etiology].
    Müller-Quernheim J
    Pneumologie; 1993 Apr; 47(4):289-302. PubMed ID: 8506252
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative studies of blood monocytes and alveolar macrophages in patients with sarcoidosis].
    Claus R; Nausch M; Zingler C; Klein M; Dietrich U; Diwok K
    Z Erkr Atmungsorgane; 1988; 170(2):185-7. PubMed ID: 3261065
    [No Abstract]   [Full Text] [Related]  

  • 39. T gamma cells in sarcoidosis: E rosetting monocytes suppress lymphocyte transformation.
    Johnson NM; Brostoff J; Hudspith BN; Boot JR; McNicol MW
    Clin Exp Immunol; 1981 Mar; 43(3):491-6. PubMed ID: 6974625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of human T cell subsets during the induction of cytotoxic T lymphocytes: the role of interleukins.
    Solbach W; Barth S; Röllinghoff M; Wagner H
    Clin Exp Immunol; 1982 Jul; 49(1):167-75. PubMed ID: 6215193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.